HTGF backs KonTEM

HTGF's early-stage investments tend to sit around the €500,000 mark. The fresh capital will help KonTEM bring its system for the examination of biological specimens with microscopes to market. The product will be launched with a business model based on recurring revenues.

Company
KonTEM is a spin-off from research centre Caesar in Bonn and Max-Planck-Innovation GmbH in Munich.

It was incorporated in 2011 in Bonn after gaining support from the German Federal Ministry of Economics and Technology through its EXIST Forschungstransfer grant.

People
Dr Andreas Olmes is senior investment manager at HTGF.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Technology
• Early-stage
• Healthcare
• High-Tech Gründerfonds